相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy Little Evidence of Improvement Over the Past 30 Years
Amye J. Tevaarwerk et al.
CANCER (2013)
Prognostic value of cyclin E expression in breast cancer: a meta-analysis
Sheng Gao et al.
TUMOR BIOLOGY (2013)
Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer
Sanjay P. Bagaria et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study
Ines Vaz-Luis et al.
BREAST CANCER RESEARCH (2012)
Functional characterization of the 19q12 amplicon in grade III breast cancers
Rachael Natrajan et al.
BREAST CANCER RESEARCH (2012)
Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era
Carlo Palmieri et al.
CLINICAL BREAST CANCER (2011)
Cyclin E Low-Molecular-Weight Isoform as a Predictor of Breast Cancer in Japanese Women
Yukiko Tokai et al.
INTERNATIONAL SURGERY (2011)
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients
Maurizio Scaltriti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Study to investigate the role of p27 and Cyclin E immunoexpression as a prognostic factor in early breast carcinoma
Komala Pillay et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
Genome profiling of ERBB2-amplified breast cancers
Fabrice Sircoulomb et al.
BMC CANCER (2010)
Low Molecular Weight Cyclin E Overexpression Shortens Mitosis, Leading to Chromosome Missegregation and Centrosome Amplification
Rozita Bagheri-Yarmand et al.
CANCER RESEARCH (2010)
Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes
Cathy B. Moelans et al.
MODERN PATHOLOGY (2010)
A novel interaction between HER2/neu and cyclin E in breast cancer
E. A. Mittendorf et al.
ONCOGENE (2010)
Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients
Hege G. Russnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
Philippe Autier et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
Vilppu J. Tuominen et al.
BREAST CANCER RESEARCH (2010)
Even Low-level HER2 Expression May be Associated With Worse Outcome in Node-positive Breast Cancer
Michael Z. Gilcrease et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Altered Subcellular Localization of Tumor-Specific Cyclin E Isoforms Affects Cyclin-Dependent Kinase 2 Complex Formation and Proteasomal Regulation
Nikki A. Delk et al.
CANCER RESEARCH (2009)
Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression
Hannah Wingate et al.
CELL CYCLE (2009)
HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005
Katri Koninki et al.
BREAST CANCER RESEARCH (2009)
Cyclin E expression and prognosis in breast cancer patients: A meta-analysis of published studies
Lei Wang et al.
CANCER INVESTIGATION (2006)
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients
AM Sieuwerts et al.
CLINICAL CANCER RESEARCH (2006)
Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: A comparative study with immunostaining
P Potemski et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cyclin E overexpression obstructs infiltrative behavior in breast cancer:: A novel role reflected in the growth pattern of medullary breast cancers.
P Berglund et al.
CANCER RESEARCH (2005)
New insights into cyclins, CDKs, and cell cycle control
I Sánchez et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays
G Callagy et al.
JOURNAL OF PATHOLOGY (2005)
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer
T Lindahl et al.
CARCINOGENESIS (2004)
Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer
S Han et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer
H Kühling et al.
JOURNAL OF PATHOLOGY (2003)
Cyclin E and survival in patients with breast cancer.
K Keyomarsi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells
JF Timms et al.
ONCOGENE (2002)
Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, cyclin E, p27kip1, and Ki-67 in normal placenta and gestational trophoblastic disease
M Olvera et al.
MODERN PATHOLOGY (2001)
Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms
DC Porter et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Cyclin E overexpression as an independent risk factor of visceral relapse in breast cancer
HK Kim et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas
IRK Bukholm et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications
R Donnellan et al.
HUMAN PATHOLOGY (2001)
分享论文
